Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6729-55-1

Post Buying Request

6729-55-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6729-55-1 Usage

Description

H-D-GLU(GLY-OH)-OH, also known as γ-D-Glutamylglycine, is a peptide composed of glutamic acid and glycine linked by a γ-glutamyl bond. It is a naturally occurring compound found in various biological systems and has been studied for its potential therapeutic properties.

Uses

Used in Pharmaceutical Industry:
H-D-GLU(GLY-OH)-OH is used as a glutamic acid antagonist for preventing polysynaptic excitant effects occurring within the spinal cord and brain in mammals. This property makes it a potential candidate for the treatment of neurological disorders and conditions related to excitotoxicity.
Used in Neuroprotection:
H-D-GLU(GLY-OH)-OH is used as a neuroprotective agent to protect neurons from damage caused by excessive stimulation of glutamate receptors. Its ability to modulate glutamate signaling pathways may contribute to its neuroprotective effects, making it a promising candidate for the development of therapies targeting neurodegenerative diseases such as Alzheimer's and Parkinson's.
Used in Cosmetic Industry:
H-D-GLU(GLY-OH)-OH is used as a skin conditioning agent in cosmetic formulations. Its moisturizing and hydrating properties help to improve skin elasticity and reduce the appearance of fine lines and wrinkles, promoting a youthful and healthy complexion.
Used in Food Industry:
H-D-GLU(GLY-OH)-OH is used as a flavor enhancer in the food industry. Its ability to modulate taste perception can improve the overall flavor profile of various food products, making it a valuable ingredient in the development of new and innovative food formulations.

Biological Activity

Broad spectrum glutamate receptor antagonist.

Check Digit Verification of cas no

The CAS Registry Mumber 6729-55-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,7,2 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 6729-55:
(6*6)+(5*7)+(4*2)+(3*9)+(2*5)+(1*5)=121
121 % 10 = 1
So 6729-55-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H12N2O5/c8-4(7(13)14)1-2-5(10)9-3-6(11)12/h4H,1-3,8H2,(H,9,10)(H,11,12)(H,13,14)/p-1/t4-/m1/s1

6729-55-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name γ-D-Glutamylglycine

1.2 Other means of identification

Product number -
Other names D-g-Glutamylglycine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6729-55-1 SDS

6729-55-1Downstream Products

6729-55-1Relevant articles and documents

Photolysis of a caged, fast-equilibrating glutamate receptor antagonist, MNI-caged γ-D-glutamyl-glycine, to investigate transmitter dynamics and receptor properties at glutamatergic synapses

Palma-Cerda, Francisco,Papageorgiou, George,Barbour, Boris,Auger, Céline,Ogden, David

, (2019/01/04)

Fast uncaging of low affinity competitive receptor antagonists can in principle measure the timing and concentration dependence of transmitter action at receptors during synaptic transmission. Here, we describe the development, synthesis and characterization of MNI-caged γ-D-glutamyl-glycine (γ-DGG), which combines the fast photolysis and hydrolytic stability of nitroindoline cages with the well-characterized fast-equilibrating competitive glutamate receptor antagonist γ-DGG. At climbing fiber-Purkinje cell (CF-PC) synapses MNI-caged-γ-DGG was applied at concentrations up to 5 mM without affecting CF-PC transmission, permitting release of up to 1.5 mM γ-DGG in 1 ms in wide-field flashlamp photolysis. In steady-state conditions, photoreleased γ-DGG at 0.55–1.7 mM inhibited the CF first and second paired EPSCs by on average 30% and 60%, respectively, similar to reported values for bath applied γ-DGG. Photolysis of the L-isomer MNI-caged γ-L-glutamyl-glycine was ineffective. The time-course of receptor activation by synaptically released glutamate was investigated by timed photolysis of MNI-caged-γ-DGG at defined intervals following CF stimulation in the second EPSCs. Photorelease of γ-DGG prior to the stimulus and up to 3 ms after showed strong inhibition similar to steady-state inhibition; in contrast γ-DGG applied by a flash at 3–4 ms post-stimulus produced weaker and variable block, suggesting transmitter-receptor interaction occurs mainly in this time window. The data also show a small and lasting component of inhibition when γ-DGG was released at 4–7 ms post stimulus, near the peak of the CF-PC EPSC, or at 10–11 ms. This indicates that competition for binding and activation of AMPA receptors occurs also during the late phase of the EPSC, due to either delayed transmitter release or persistence of glutamate in the synaptic region. The results presented here first show that MNI-caged-γ-DGG has properties suitable for use as a synaptic probe at high concentration and that its photolysis can resolve timing and extent of transmitter activation of receptors in glutamatergic transmission.

Isolation and identification of urinary β-aspartyl dipeptides and their concentrations in human urine

Tanaka,Nakajima

, p. 617 - 625 (2007/10/05)

β-Aspartyl-methionine, -aspartic acid and -glutamic acid and γ-glutamyl-threonine and -glycine were isolated and identified in human urine by means of ion-exchange chromatography, highvoltage paper electrophoresis, acid hydrolysis and determination of N-terminal amino acids of the isolated compounds, and comparison of their behaviors in paper electrophoresis and chromatography with those of the authentic compounds. The concentrations of acidic β-aspartyl dipeptides in human urine were determined using an amino acid analyzer. Their concentrations were as follows: β-aspartyl-glycine, male, 44.4±8.5, female, 61.4±18.9, child, 83.7±27.1; -alanine, male, 11.0±4.9, female, 20.7±12.0, child, 25.3±9.1; -glutamic acid, male, 10.0±3.7, female, 23.0±8.5, child, 20.4±7.5; -serine, male, 9.9±2.8, female, 13.6±3.8, child, 14.9±4.7; -aspartic acid, male, 4.3±1.0, female, 9.1±2.2, child, 18.4±6.5; -threonine, male, 3.9±0.9, female, 5.8±1.1, child, 13.2±4.9 μmol/g creatinine (mean ± S.D.). The order of the sum of their concentrations tended to be child>female>male. Patients receiving intravenous hyperalimentation also excreted acidic β-aspartyl dipeptides into urine in amounts similar to those in females and in a pattern similar to that observed in healthy persons. This finding indicates that urinary β-aspartyl dipeptides were probably of endogenous origin because oral nutrition was stringently excluded in these patients.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6729-55-1